Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan

Metabolism: Clinical and Experimental

Volumn 58, Issue 6, 2009, Pages 772-778

  Chen, Pei Chun ^a   Chien, Kuo Liong ^b,c   Hsu, Hsiu Ching ^c   Su, Ta Chen ^c   Sung, Fung Chang ^a,b   Lee, Yuan Teh ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STROKE; TAIWAN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TAIWAN;

EID: 65549107812     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.01.006     Document Type: Article

References (29)

1. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
2. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
3. Rost N.S., Wolf P.A., Kase C.S., Kelly-Hayes M., Silbershatz H., Massaro J.M., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
4. Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108 (2003) 166-170
5. Curb J.D., Abbott R.D., Rodriguez B.L., Sakkinen P., Popper J.S., Yano K., and Tracy R.P. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107 (2003) 2016-2020
6. Wakugawa Y., Kiyohara Y., Tanizaki Y., Kubo M., Ninomiya T., Hata J., et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke 37 (2006) 27-32
7. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003) 2317-2322
8. Bos M.J., Schipper C.M., Koudstaal P.J., Witteman J.C., Hofman A., and Breteler M.M. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 114 (2006) 1591-1598
9. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
10. Ridker P.M., Wilson P.W., and Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 109 (2004) 2818-2825
11. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
12. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
13. Lloyd-Jones D.M., Liu K., Tian L., and Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145 (2006) 35-42
14. Sattar N., Murray H.M., McConnachie A., Blauw G.J., Bollen E.L., Buckley B.M., et al., PROSPER Study Group. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115 (2007) 981-989
15. Lee Y., Lin R.S., Sung F.C., Yang C., Chien K., Chen W., et al. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53 (2000) 838-846
16. Chien K.L., Sung F.C., Hsu H.C., Su T.C., Lin R.S., and Lee Y.T. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study. Stroke 33 (2002) 39-44
17. Vukovich T.C., Mustafa S., Rumpold H., and Wagner O. Evaluation of a turbidimetric Denka Seiken C-reactive protein assay for cardiovascular risk estimation and conventional inflammation diagnosis. Clin Chem 49 (2003) 511-512
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
19. Internal Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed June 28, 2008.
20. Hosmer Jr. D.W., and Lemeshow S. Applied logistic regression (1989), John Wiley & Sons press, New York
21. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
22. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
23. Wannamethee S.G., Shaper A.G., Lennon L., and Morris R.W. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165 (2005) 2644-2650
24. Najarian R.M., Sullivan L.M., Kannel W.B., Wilson P.W., D'Agostino R.B., and Wolf P.A. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 166 (2006) 106-111
25. Ishizaka N., Ishizaka Y., Hashimoto H., Toda E., Nagai R., and Yamakado M. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension 48 (2006) 411-417
26. Forouhi N.G., and Sattar N. CVD risk factors and ethnicity-a homogeneous relationship?. Atheroscler Suppl 7 (2006) 11-19
27. Albert M.A., Glynn R.J., Buring J., and Ridker P.M. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
28. Anand S.S., Razak F., Yi Q., Davis B., Jacobs R., Vuksan V., et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24 (2004) 1509-1515
29. Khera A., McGuire D.K., Murphy S.A., Stanek H.G., Das S.R., Vongpatanasin W., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469